Delivery Order SPE2DB22D3501-SPE2DB23FXJ31

Award Date 9/25/23
Potential Completion Date 10/17/23
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $14,767 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561435772 BENLYSTA 400 MG VIALS. The contract has a period of performance from July 7, 2023 through July 28, 2023, with performance taking place in Conshohocken, Pennsylvania. This delivery order is likely placed against DLA's Pharmaceutical Prime Vendor contract, a multiple award IDIQ used to fulfill pharmaceutical needs for DOD and other agencies. No subcontractors or set...
The Defense Logistics Agency awarded a $2,461.18 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561491082 BENLYSTA 400 MG VIALS. The place of performance is Conshohocken, Pennsylvania. The period of performance is from July 13, 2023 through August 3, 2023. This delivery order was awarded under an existing DLA pharmaceutical supply vehicle to provide the specified pharmaceutical products in support of DOD health programs. No set aside designation or subcontractors were...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $4,922.36 to provide 4562141151 BENLYSTA 400 MG VIALS. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is from September 12, 2023 through October 3, 2023. No subcontractors or set aside designations were identified. This order is likely in support of the DLA's stockpile of pharmaceuticals and medical supplies to...
The Defense Logistics Agency awarded a $16,209.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for BENLYSTA 200 MG/ML autoinjectors. The contract has a period of performance from July 26, 2023 through August 16, 2023, with all work taking place in Conshohocken, Pennsylvania. DLA utilizes such delivery orders under existing Prime Vendor contracts to procure pharmaceutical products in support of the military health system. No subcontractors or set-aside designations were...
The Defense Logistics Agency Troop Support Medical awarded a $11,695.32 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg vials of Benlysta. The contract has a period of performance from September 26, 2023 through October 18, 2023. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No set aside designation or subcontractors were identified. This delivery order appears to be under the DLA's Prime Vendor program to supply...
The Defense Logistics Agency awarded a $14,767 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg vials of Benlysta. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 15, 2023. The DLA manages the Department of Defense's supply chain and procurement programs, suggesting this contract supports medical readiness initiatives across the armed forces. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a $16,987.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg vials of Benlysta. The prime contractor will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania by August 30, 2023. The Defense Logistics Agency supports Department of Defense procurement programs by acquiring and providing logistics support for medical supplies and pharmaceuticals. No set aside designation or subcontractors were...
The Defense Logistics Agency awarded a $5,402.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561422852 BENLYSTA 200 MG/ML AUTOINJECTML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on July 6, 2023 and concluding on July 27, 2023. As the DLA supports procurement for the Department of Defense, this delivery order is likely associated with...
The Defense Logistics Agency awarded a $12,306 delivery order to Amerisourcebergen Drug Corporation for 4561498874 BENLYSTA 400 MG VIALS. This firm fixed price order is being carried out under the Prime Vendor Pharmaceutical program, with performance taking place in Conshohocken, Pennsylvania through August 4, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the Department of Defense's global supply chain and works to ensure medical...
The Defense Logistics Agency awarded a $1,110.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg vials of Benlysta. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its Conshohocken, Pennsylvania location by October 23, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated. The delivery order was awarded under an existing DLA...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB23FXJ31
    Delivery Order

The Defense Logistics Agency awarded a $19,208.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562300652 BENLYSTA 400 MG VIALS. The contract has a period of performance from September 25, 2023 through October 17, 2023, with all work taking place in Conshohocken, Pennsylvania. This delivery order is likely placed against DLA's Pharmaceutical Prime Vendor contract, a multiple award indefinite delivery/indefinite quantity vehicle used to procure prescription drugs and related pharmaceuticals in support of the military health system. No subcontractors or set aside designations were indicated.

Generated 12/25/23, 10:06 AM